BDAR
gdpr

Patients with type 1 diabetes will receive reimbursement for continuous glucose monitoring systems

Date

2022 06 28

Rating
1
1557_aeb75d5906ef65f75701c0a25976385f.jpg

The continuous glucose monitoring system will be reimbursed for all patients with type 1 diabetes from the Compulsory Health Insurance Fund (CHIF) as of 1 July 2022. Patients, used to measuring their glucose levels by taking a blood sample from a finger and wishing to continue to do so will continue to have their diagnostic strips reimbursed. The procedure of reimbursement of diagnostic strips has been updated based on the technological characteristics of sensors in different devices.

The medical measures will be compensated only for a single glucose measurement method of the patient's choice. This means that people having their continuous glucose monitoring systems reimbursed will not be eligible to a reimbursement of diagnostic strips during the same treatment period. In the same way, persons with type 1 diabetes, who get a reimbursement for the rental costs of an insulin pump with an integrated continuous glucose measurement sensor, will not be eligible to a reimbursement of a continuous glucose monitoring system.

However, patients who have been prescribed diagnostic strips before 1 July, will not have to wait until they use them all – they will be able to get a reimbursed continuous glucose monitoring system any time, regardless of the term until which the patient should have enough of the previously prescribed diagnostic strips.

A continuous glucose monitoring system can be prescribed by an endocrinologist, paediatric endocrinologist, internist, paediatrician or general physician, and a system itself can be purchased at a pharmacy.

Continuous glucose monitoring systems are fast and convenient. The system’s sensor keeps monitoring the blood glucose, while the transmitter sends the sensor's glucose information to a smart device, such as a mobile phone.

According to the National Health Insurance Fund (NHIF) under the Ministry of Health, in the first year, the reimbursement of continuous glucose monitoring systems will be allocated approximately 3 million Eur from CHIF. In one year, patients with type 1 diabetes will be able to have a reimbursement for one of the following sets:

• up to 36 sensors, replaceable every 10 days, and 4 transmitters, replaceable every 3 months;
• up to 26 sensors, replaceable every 14 days, and 1 transmitter, replaceable every 12 months.

Patients with type 1 diabetes, who measure their blood glucose levels by taking blood samples from a finger or who use insulin pumps, the different sensors of which must be calibrated using diagnostic strips at a different frequency due to their technological characteristics, will have the diagnostic strips reimbursed according to the new procedure. It establishes a different amount of diagnostic strips based on the sensors calibration frequency.

According to the updated reimbursement procedure for type 1 diabetes patients, diagnostic strips can be prescribed as follows:

1. Up to 150 strips per month (1,800 strips per year) for children and persons under 24 years with type 1 diabetes, who use only diagnostic strips for glycaemic assessment and who are not eligible to reimbursement of the rental costs of insulin pumps with integrated continuous glucose monitoring sensors or continuous glucose monitoring systems;
2. Up to 75 strips per month (900 strips per year) for children and persons under 24 years with type 1 diabetes, who use only diagnostic strips for glycaemic assessment and who are not eligible to reimbursement of the rental costs of insulin pumps with integrated continuous glucose monitoring sensors or continuous glucose monitoring systems;
3. 50-75 strips per month (up to 750 strips per year) for persons with type 1 diabetes, who use a reimbursed glucose measurement sensor, integrated into their insulin pump and calibrated twice a day using diagnostic strips;
4. Up to 100 strips per 3 months (up to 400 strips per year) for persons with type 1 diabetes, who use a reimbursed glucose measurement sensor, integrated into their insulin pump and calibrated once a day using diagnostic strips.

It’s important to note that the number of the strips, indicated in points 3 and 4 is prescribed to patients regardless of their age.

The Ministry of Health would like to encourage patients to contact their general or specialising physician and use the assistance, offered by the state, to acquire the innovative measures to control their condition in a more effective and convenient way.

Information from NHIF and the Press Office of the Ministry of Health

(Piktochart pict.)

The NHIF invites you:

Your questions are welcome by email [email protected] or phone: local (8 5) 232 2222, international +370 5 232 222